Al Sandrock, Voyager Therapeutics CEO (via YouTube)

San­drock’s first month at Voy­ager sours as shares crum­ble on Levin, Paul’s move to step off the board

Voy­ager Ther­a­peu­tics was able to poach Al San­drock out of his very, very brief re­tire­ment from Bio­gen to right its wa­ver­ing gene ther­a­py ship af­ter …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.